Immunology and immunotherapy of colorectal cancer
- 20 February 2003
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 46 (1) , 33-57
- https://doi.org/10.1016/s1040-8428(02)00159-2
Abstract
No abstract availableKeywords
This publication has 185 references indexed in Scilit:
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal Of Cancer, 2001
- CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon CancerAnnals of Surgical Oncology, 2001
- Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancerEuropean Journal Of Cancer, 1999
- 5-Fluorouracil plus interferon α-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: A multicentric randomized studyZeitschrift für Krebsforschung und Klinische Onkologie, 1998
- Phase I/II trial of autologous activated macrophages in advanced colorectal cancerEuropean Journal Of Cancer, 1996
- Survival for colon and rectal cancer in a population-based cancer registryEuropean Journal Of Cancer, 1996
- Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responsesImmunology Today, 1995
- Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophagesEuropean Journal Of Cancer, 1995
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- An explanation of the variable clinical response to interleukin 2 and LAK cellsImmunology Today, 1990